AXIM Nuclear and Oncology
AXIM Nuclear and Oncology is a trusted partner in the radiation oncology field, dedicated to providing progressive solutions that enhance cancer care. We collaborate with world-renowned suppliers to deliver innovative technologies that optimize treatment precision, patient safety, and clinical efficiency. From dosimetry and quality assurance systems to immobilization and Surface Guided Radiation Therapy (SGRT) solutions, AXIM Nuclear and Oncology supports healthcare providers with comprehensive tools tailored to meet the evolving demands of modern oncology.
Our team of radiotherapy-trained and experienced sales professionals bring in-depth clinical knowledge to every interaction. This ensures that our clients receive expert guidance and tailored solutions to meet their specific needs. Our commitment to excellence and clinical expertise ensures we remain at the forefront of empowering clinicians to achieve the best possible outcomes for their patients.
The versatile Xoft® Axxent® Electronic Brachytherapy (eBx®) System® utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy tissue.
Miniaturized x-ray source
Our proprietary, miniaturized x-ray source is isotope-free and operates at 50 kV to deliver high dose rate, low energy radiation. The source is placed inside the applicator and energized to deliver a precise, prescribed dose of radiation. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy tissue.
VISICOIL™ is a helically wound gold or platinum linear fiducial marker in the form of a coil used for Soft Tissue Tumor Localization.
VISICOIL are available preloaded in various needle gauges with multiple marker sizes and lengths. This helps you choose the right implant method for your patient and imaging technique. The elongated design allows for fewer markers and a more stable marker localization from implant through treatment
See it. Trust it. Treat it.
At Macromedics, innovation is more than a value — it’s the driving force. By prioritising open and direct communication with radiotherapy professionals, we stay ahead of emerging trends in radiation oncology. Allowing us to continually refine our existing products and develop one-of-a-kind innovations that redefine patient positioning and treatment accuracy.
Macromedics design philosophy is centered on supporting efficient and precise radiotherapy treatment through optimized patient positioning and streamlined workflow efficiency for healthcare professionals. To achieve this, we create lightweight, modular products that prioritize patient comfort—a critical factor in ensuring successful setup, diagnosis, and treatment.
Patient comfort directly translates to patient control, leading to better outcomes.
The Precision Experts, Orfit, is a global pioneer in thermoplastic and immobilization solutions, known for providing high-precision systems that enhance patient positioning in radiation therapy.
Orfit’s versatile product range includes immobilization devices tailored for head and neck, breast, and full-body treatments, supporting advanced techniques like intensity-modulated radiation therapy (IMRT) and stereotactic treatments.
Orfit thermoplastic materials offer patient-specific moulds that ensure consistent and reproducible setups, improving both patient comfort and treatment accuracy.
With a strong focus on innovation and ease of use, Orfit immobilization solutions are relied upon to deliver optimal treatment outcomes and safety in radiation oncology.
Sun Nuclear is part of Mirion Medical, a group of healthcare-focused brands within Mirion. We provide innovative solutions for Radiation Therapy and Diagnostic Imaging centers. More than 5,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, Sun Nuclear aims to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety.
Visit us: sunnuclear.com
Sensus Healthcare, Inc. is a medical device company specializing in low-energy photon radiotherapy known as superficial radiation therapy (SRT), to treat non-melanoma skin cancers and keloids.
SRT provides compassionate dermatologists and oncologists around the world with an effective non-surgical treatment option for both oncological and non-oncological conditions. Unlike surgery, SRT does not require any incisions or anesthesia. This means that there is a minimal risk of scarring, bleeding or infection, and the patient can continue normal activities throughout the course of treatment.
https://sensushealthcare.com/blog/
SGRT applications are particularly valuable in treatments requiring high precision, such as breast cancer treatments using deep inspiration breath hold (DIBH) and stereotactic treatments, where millimeter-level accuracy is critical. By using real-time 3D surface imaging,
VisionRT systems are trusted to enhance safety, streamline workflows, and improve outcomes by ensuring patients remain in the correct position throughout their radiation therapy sessions. This technology eliminates the need for invasive markers or permanent tattoos, improving patient comfort while ensuring accurate treatment delivery.
Vision RT | Full Patient Journey
Accurate patient identification is critical in radiotherapy to ensure the safety and precision of treatments. Traditionally, identification relies on manual checks, such as verifying a patient’s date of birth or using photographs. However, these methods are prone to human error and are not seamlessly integrated into the treatment workflow, leaving room for inconsistencies.
CNERGY Go! takes patient identification to the next level by integrating biometric palm vein scanning directly into the radiotherapy workflow. This system uses the unique blood vessel patterns in a patient’s palm for identification. Palm vein biometrics are exceptionally accurate—outperforming facial recognition and iris scanning methods—while being fast, reliable, and suitable even for patients undergoing treatments like chemotherapy that may temporarily alter fingerprints.
How It Works – Before each treatment, the patient places their hand on a scanner while positioned on the treatment table. The system verifies their identity in real time, and the treatment cannot proceed until positive identification is confirmed. If a patient is unable to use the scanner, a radiation technologist can securely override the system using their own unique palm signature. This ensures seamless treatment delivery without compromising safety.
CNERGY Go! can also be expanded with additional features, such as a waiting room module or self-service kiosk, further optimizing clinic workflows and improving the patient experience.
Total Body Irradiation (TBI) can be a complex treatment and may take up to an hour. Patient movements or positioning difficulties can double the time required. CNERGY TBI aims to help you significantly improve Total Body Irradiation treatment setup procedures and outcomes. Instead of simply producing a single image, the solution relies on Intrafraction Monitoring in the form of live video capture to provide 1376 x 1024 resolution (14 bits/pixel) MV images. Video captures can be stopped and restarted to accommodate for changes in the patient’s position or block/ compensator positions – so there’s no risk of needing to repeat the entire patient setup procedure. This will deliver greater efficiency and improved treatment quality compared to the classic film cassette methods.
Sirtex is a global leader in interventional oncology, specializing in Selective Internal Radiation Therapy (SIRT) with their innovative SIR-Spheres® Y-90 resin microspheres.
SIRT is a minimally invasive treatment that delivers targeted radiation directly to liver tumours, using tiny radioactive beads (microspheres) that lodge in the blood vessels feeding the tumours. This approach is particularly effective for patients with inoperable liver cancer, including those with metastatic colorectal cancer or hepatocellular carcinoma. Sirtex’s cutting-edge therapy allows for high-dose radiation to be delivered precisely to cancer cells while sparing surrounding healthy tissue, providing a life-extending treatment option with minimal side effects.
Trusted by physicians worldwide, Sirtex’s SIRT technology is a vital option in the fight against liver cancer.
Sirtex Patient Guide